Acurx Pharmaceuticals (ACXP) Assets (2020 - 2026)
Acurx Pharmaceuticals' (ACXP) quarterly Assets came in at $9.5 million in Q1 2026, up 98.52% YoY from $4.8 million in Q1 2025, and up 24.06% on a QoQ basis from $7.7 million in Q4 2025.
Acurx Pharmaceuticals (ACXP) Assets (2020 - 2026) Analysis & Trends
Acurx Pharmaceuticals (ACXP) has 7 years of Assets data on file, last reported at $9.5 million in Q1 2026.
- Quarterly Assets rose 98.52% year-over-year to $9.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.5 million (up 98.52% YoY) and the FY2025 annual result came in at $7.7 million, up 99.32% from the prior year.
- Assets advanced to $9.5 million in Q1 2026, from $7.7 million in the prior quarter.
- In the past five years, Assets ranged from a high of $11.3 million in Q1 2022 to a low of $3.9 million in Q4 2024.
- A 5-year average of $7.8 million and a median of $7.7 million in 2025 frame the typical range for Assets.
- Annual changes were most pronounced in 2024 — Assets sank 49.96% — and 2025, when it jumped 99.32%.
- Tracing ACXP's Assets over 5 years: stood at $9.4 million in 2022, then dropped by 17.78% to $7.7 million in 2023, then slumped by 49.96% to $3.9 million in 2024, then surged by 99.32% to $7.7 million in 2025, then grew by 24.06% to $9.5 million in 2026.
- The last three Assets figures came in at $9.5 million (Q1 2026), $7.7 million (Q4 2025), and $6.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Acurx Pharmaceuticals | 6.38 Mn | 6.38 Mn | - | 10.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.98 Mn |
| Mar 31, 2026 | 9.54 Mn |
| Dec 31, 2025 | 7.69 Mn |
| Sep 30, 2025 | 6.11 Mn |
| Jun 30, 2025 | 6.16 Mn |
| Mar 31, 2025 | 4.81 Mn |
| Dec 31, 2024 | 3.86 Mn |
| Sep 30, 2024 | 5.98 Mn |
| Jun 30, 2024 | 6.58 Mn |
| Mar 31, 2024 | 9.11 Mn |
| Dec 31, 2023 | 7.71 Mn |
| Sep 30, 2023 | 7.16 Mn |
| Jun 30, 2023 | 9.24 Mn |
| Mar 31, 2023 | 7.39 Mn |
| Dec 31, 2022 | 9.38 Mn |
| Sep 30, 2022 | 10.95 Mn |
| Jun 30, 2022 | 9.26 Mn |
| Mar 31, 2022 | 11.32 Mn |
| Dec 31, 2021 | 13.25 Mn |
| Sep 30, 2021 | 14.99 Mn |